
Genetron Holdings Limited GTH
Geschäftsbericht 2022
hinzugefügt 21.12.2024
Genetron Holdings Limited Zahlungsmittel 2011-2026 | GTH
Zahlungsmittel Jährlich Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 176 M | 639 M | 1.38 B | 140 M | 140 M | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.38 B | 140 M | 494 M |
Zahlungsmittel Vierteljährlich Genetron Holdings Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 639 M | - | - | - | 1.38 B | - | - | - | 140 M | - | - | - | 62.1 M | - | - | - | 42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.38 B | 42 M | 452 M |
Zahlungsmittel anderer Aktien in der Diagnostik & Forschung
| Name | Zahlungsmittel | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
11.9 M | $ 1.48 | -9.51 % | $ 1.97 M | ||
|
Castle Biosciences
CSTL
|
117 M | $ 18.95 | 0.4 % | $ 549 M | ||
|
Fulgent Genetics
FLGT
|
55.1 M | $ 15.85 | -2.1 % | $ 479 M | ||
|
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 18.56 | - | $ 196 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 112.0 | -1.1 % | $ 34 B | ||
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
2.5 M | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
65.4 M | $ 20.15 | -1.66 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
359 M | $ 95.11 | -1.61 % | $ 6.42 B | ||
|
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M | ||
|
Medpace Holdings
MEDP
|
497 M | $ 417.38 | -0.43 % | $ 12 B | ||
|
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | ||
|
Mettler-Toledo International
MTD
|
66.9 M | $ 1 036.33 | -0.53 % | $ 21.4 B | ||
|
Myriad Genetics
MYGN
|
150 M | $ 3.63 | 0.14 % | $ 336 M | ||
|
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
160 M | $ 8.31 | -0.6 % | $ 1.06 B | ||
|
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B | ||
|
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
214 M | $ 158.4 | -0.56 % | $ 7.85 B | ||
|
National Research Corporation
NRC
|
4.14 M | $ 18.87 | -0.3 % | $ 422 M | ||
|
Natera
NTRA
|
466 M | $ 191.02 | -2.99 % | $ 18.8 B | ||
|
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 25.35 | -0.63 % | $ 24 B | ||
|
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
378 M | $ 96.33 | -2.36 % | $ 12.1 B | ||
|
Senseonics Holdings
SENS
|
40.2 M | $ 5.71 | -1.89 % | $ 238 M | ||
|
Personalis
PSNL
|
124 M | $ 6.55 | -2.38 % | $ 585 M | ||
|
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
752 M | $ 115.8 | -1.11 % | $ 9.55 B | ||
|
Illumina
ILMN
|
1.13 B | $ 139.62 | -2.53 % | $ 22.2 B | ||
|
Soleno Therapeutics
SLNO
|
70.1 M | $ 52.99 | -0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | ||
|
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.58 | -0.63 % | $ 208 M | ||
|
Biomerica
BMRA
|
2.4 M | $ 2.42 | 0.41 % | $ 5.56 M | ||
|
Twist Bioscience Corporation
TWST
|
183 M | $ 50.69 | -4.27 % | $ 3.03 B | ||
|
Thermo Fisher Scientific
TMO
|
9.85 B | $ 439.8 | -1.86 % | $ 166 B | ||
|
Laboratory Corporation of America Holdings
LH
|
532 M | $ 253.87 | -0.09 % | $ 21.1 B | ||
|
Celcuity
CELC
|
166 M | $ 133.09 | -1.21 % | $ 6.22 B | ||
|
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
588 M | $ 329.45 | -1.15 % | $ 19.6 B | ||
|
Neogen Corporation
NEOG
|
129 M | $ 8.39 | -0.47 % | $ 1.82 B |